5 results match your criteria The American Journal of Hematology/Oncology [Journal]

  • Page 1 of 1

Case Report: Unusual Manifestation of Negative Systemic Mastocytosis.

Am J Hematol Oncol 2016 Dec;12(12):24-27

Department of Hematology-Oncology of the VA Caribbean Healthcare System, 10 Calle Casia, San Juan, Puerto Rico 00921.

Aggressive systemic mastocytosis is a rare hematologic neoplastic disease that presents with a poor prognosis and low survival rate. It typically manifests with symptoms associated to mast cell release of bioactive substances, causing anaphylaxis, flushing, autonomic and hemodynamic instability, gastric distress and headache. Moreover, more than 95% of cases are related to a mutation in codon 816 of the gene, located on human chromosome 4q12 which codes for a type III receptor tyrosine kinase. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573261PMC
December 2016
11 Reads

PET/CT in the Evaluation of Relapsed or Refractory Hodgkin Lymphoma.

Am J Hematol Oncol 2016 Sep;12(9):8-13

Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia.

18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) has been the most important advance in the assessment of Hodgkin lymphoma (HL) since the introduction of computed tomography (CT). In the frontline management of HL, FDG-PET combined with low-dose CT has emerged as the modality of choice for staging and treatment response assessment. Substantial data have accumulated over the past several years supporting the use of PET/CT in the evaluation and management of relapsed or refractory HL, as well. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810973PMC
September 2016
4 Reads

Effect of Vitamin D Supplementation on Breast Cancer Biomarkers: CALGB 70806 (Alliance) Study Design and Baseline Data.

Am J Hematol Oncol 2016 Jul;12(7):4-9

Division of Hematology and Oncology, Department of Medicine, University of Vermont, Burlington VT.

One in eight women will develop breast cancer over their lifetime with 230,000 women diagnosed in 2015. For this reason, breast cancer prevention efforts are essential. Vitamin D, with anticancer properties, may have a role in prevention of some cancers, including breast cancer. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656380PMC
July 2016
21 Reads

Risks of Venous Thromboembolism and Mortality Associated With Erythropoiesis-Stimulating Agents for the Treatment of Cancer-Associated Anemia.

Am J Hematol Oncol 2008 Aug;7(8):327-332

VA Chicago Healthcare System and the VA Center for the Management of Complex Chronic Care, Chicago, Illinois; Division of Hematology/Oncology of the Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3156058PMC
August 2008
4 Reads

Management decisions for nodal metastasis from an unknown primary melanoma.

Am J Hematol Oncol 2008 Jul;7(7):306-308

Roy E. Coats Research Laboratories and the Sonya Valley Ghidossi Vaccine Laboratory of the John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, CA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3115657PMC
July 2008
3 Reads
  • Page 1 of 1